Skip to main content
Clinical Trials/ACTRN12608000234314
ACTRN12608000234314
Completed
Phase 4

A prospective, multicenter, non-randomized study to evaluate the safety and efectiveness of the R3 Acetabular Hip System in patients with degenerative joint disease.

Smith & Nephew0 sites70 target enrollmentMay 7, 2008

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Degenerative joint disease.
Sponsor
Smith & Nephew
Enrollment
70
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 7, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patient is of legal age to consent and skeletally mature.
  • 2\. Patient requires primary total hip arthroplasty due to non\-inflammatory degenerative joint disease (e.g. osteoarthritis, traumatic arthritis, avascular necrosis, and dysplasia/DDH).
  • 3\.Patient has met an acceptable preoperative medical clearance and is free from or treated for cardiac, pulmonary, hematological, etc., conditions that would pose excessive operative risk.
  • 4 The patient will be available for follow\-up throughout the duration of the study.

Exclusion Criteria

  • Subjects with any of the following characteristics must be excluded from
  • participation in the study.
  • 1\.Patient has active infection or sepsis (treated or untreated)
  • 2\.Patient has any vascular insufficiency, muscular atrophy, or
  • neuromuscular disease severe enough to compromise implant stability or
  • postoperative recovery.
  • 3\.Patient is female of child\-bearing age and not taking contraceptive
  • precautions
  • 4\.Patient has inadequate bone stock to support the device (e.g. severe
  • osteopenia, family history of severe osteoporosis or osteopenia)

Outcomes

Primary Outcomes

Not specified

Similar Trials